Maie S Taha

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Silver Nanoparticles

Top Venues

Molecular pharmaceutics

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Maie S Taha, Shallu Kutlehria, Anisha A D'Souza, Benjamin S Bleier, Mansoor M Amiji
Topical Administration of Verapamil in Poly(ethylene glycol)-Modified Liposomes for Enhanced Sinonasal Tissue Residence in Chronic Rhinosinusitis: Ex Vivo and In Vivo Evaluations. Molecular pharmaceutics (2023)
Maie S Taha, Shallu Kutlehria, Anisha A D'Souza, Benjamin S Bleier, Mansoor M Amiji
Topical Administration of Verapamil in Poly(ethylene glycol)-Modified Liposomes for Enhanced Sinonasal Tissue Residence in Chronic Rhinosinusitis: Ex Vivo and In Vivo Evaluations. Molecular pharmaceutics 20 (3) (2023)
Maie S Taha, Shallu Kutlehria, Anisha A D'Souza, Benjamin S Bleier, Mansoor M Amiji
Topical Administration of Verapamil in Poly(ethylene glycol)-Modified Liposomes for Enhanced Sinonasal Tissue Residence in Chronic Rhinosinusitis: Ex Vivo and In Vivo Evaluations. Molecular pharmaceutics 20 (3) (2023)
Maie S Taha, Shallu Kutlehria, Anisha A D'Souza, Benjamin S Bleier, Mansoor M Amiji
Topical Administration of Verapamil in Poly(ethylene glycol)-Modified Liposomes for Enhanced Sinonasal Tissue Residence in Chronic Rhinosinusitis: Ex Vivo and In Vivo Evaluations. Molecular pharmaceutics 20 (3) (2023)
Simseok A Yuk, Hyungjun Kim, Nader S Abutaleb, Alexandra M Dieterly, Maie S Taha, Michael D Tsifansky, L Tiffany Lyle, Mohamed N Seleem, Yoon Yeo
Nanocapsules modify membrane interaction of polymyxin B to enable safe systemic therapy of Gram-negative sepsis. Science advances 7 (32) (2021)